Broussonetine A
CAS: 173220-07-0
Ref. 3D-YGA22007
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Broussonetine A is a unique alkaloid that has gained attention for its various properties and applications. It is known for its ability to crystallize, making it valuable in the field of crystallography. Broussonetine A has also been found to have potential as a carbapenem, a class of antibiotics used to treat severe infections. Its bioavailability and efficacy against resistant bacteria make it a promising candidate in the fight against antibiotic resistance.
In addition to its antibacterial properties, Broussonetine A has shown inhibitory effects on caspase-11 and caspase-9, enzymes involved in programmed cell death. This suggests potential applications in cancer research and therapy. Furthermore, it has demonstrated hyaluronidase activity, which may have implications in wound healing and tissue regeneration.
Potassium plays a crucial role in various physiological processes, and Broussonetine A has been found to modulate potassium channels. This characteristic makes it an interesting compound for further investigation in
